Long term rate control w BBs or non DHP CCBs as 1st line

By rray, 24 January, 2024
Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> Hindricks G, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. <i>Eur Heart J.</i> 2021 Feb 1;42(5):373-498. <a href=https://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehaa612/33799442/ehaa612.pdf><u>Free, full-text PDF</u></a>
Detail Type
Text
Detail Text
If BBs CCBs contraindicated not tolerated or not preferred digoxin is option Target digoxin level
Avoid dronedarone in pts w CV risk factors
If pregnant BB or digoxin 1st line for rate control
Target HR based on sx Aim for
Patient Type Detail Header (Long)
Long-term rate control w/ BBs or non-DHP CCBs as 1st line.